In his current roles, Dr. Efron oversees and coordinates all clinical activity for Johns Hopkins Medicine’s 4,200 faculty providers, as well as community physicians and a rapidly expanding employed provider group. Among his many achievements, Dr. Efron developed an integrated ambulatory accountability and oversight structure. Similarly, he helped design and launch Johns Hopkins Medicine’s Clinical Road Map, focusing on workforce development, and physical and virtual expansion. He also implemented a clinical outcomes research unit to allow for the mentorship and development of medical students and residents focused on colorectal diseases.
At UT Southwestern, he will oversee the clinical enterprise, including UTSW’s Medical Group, hospitals, regional medical centers, and clinics. Dr. Efron also will be responsible for strategic, operational, and service-related performance, and he will partner with senior leaders across the institution to proactively address the evolving health care environment. Along with serving as EVP for Health System Affairs at UT Southwestern, Dr. Efron will hold an appointment as Professor of Surgery.

Ad Statistics
Times Displayed: 112448
Times Visited: 6718 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
In addition to his series of leadership positions held at Johns Hopkins over the past 14 years, Dr. Efron specializes in the treatment of colorectal cancer. He earned his medical degree from the University of Maryland School of Medicine in Baltimore, completed residency at Long Island Jewish Medical Center, and did his fellowship at the Cleveland Clinic of Florida. He was later appointed to academic and surgical positions at Mayo Clinic College of Medicine.
More about UT Southwestern
UT Southwestern has received national distinction for patient satisfaction and quality of care from multiple reviewing bodies, such as the Centers for Medicare & Medicaid Services, Leapfrog, Healthgrades, and Press Ganey. In 2023, UT Southwestern earned the Guardian of Excellence Award, recognizing the top 5% of health care providers, and it is ranked second overall in Comprehensive Academic Medical Centers for Patient Experience by Vizient, which includes 97% of all academic medical centers (AMCs). Forbes and Statista recognize UT Southwestern among America’s Best Large Employers, Best Employers for New Grads, Best Employers for Diversity, and Best Employers for Women.
UT Southwestern’s Nursing Division has achieved Magnet designation, the highest honor awarded by the American Nurses Credentialing Center (ANCC), and Clements University Hospital is an Advanced Comprehensive Stroke Center, the highest level of certification for stroke care. UT Southwestern Medical Center also encompasses the Harold C. Simmons Comprehensive Cancer Center, the region’s only National Cancer Institute Comprehensive Cancer Center, and the Peter O’Donnell Jr. Brain Institute, which involves more than 2,100 faculty and staff, including nearly 400 clinical and research faculty in 200 areas of specialty care. In late 2025, UT Southwestern, in partnership with the Texas Department of Health and Human Services, will open the Texas Behavioral Health Center at UT Southwestern, the first state psychiatric hospital in the Dallas-Fort Worth region to help address the state’s growing mental health care needs.
UT Southwestern Medical Center includes four degree-granting institutions: UT Southwestern Medical School, UT Southwestern Graduate School of Biomedical Sciences, UT Southwestern School of Health Professions, and UT Southwestern Peter O’Donnell Jr. School of Public Health. Collectively, the schools train nearly 3,700 medical, graduate, and health profession students, residents, and postdoctoral fellows each year, and include some of the nation’s and state’s largest residency programs and the largest public GME program in Texas. UT Southwestern conducts nearly $640 million in research and is ranked as the top-rated public institution and No. 3 among global health care institutions in the 2023 Nature Index for its published research.
Back to HCB News